DES Drug Scandal Affects Generations in UK
Analysis based on 14 articles · First reported Mar 10, 2026 · Last updated Mar 10, 2026
The Diethylstilbestrol (DES) scandal highlights significant long-term health and legal risks for pharmaceutical companies that produced and distributed the drug. The push for a public inquiry and compensation scheme in the United Kingdom could lead to substantial financial liabilities and increased regulatory scrutiny for the pharmaceutical industry.
Maxwell Samuda, a former Love Island contestant, has become the first man to publicly discuss his health issues, including reproductive system problems, which he believes are linked to his grandmother Maureen Day's exposure to the cancer-linked pregnancy drug Diethylstilbestrol (DES) in the 1970s. His mother, Natalie Samuda, also suffers from severe health conditions attributed to DES. The family is backing the campaign group DES Justice UK's call for a public inquiry and a compensation scheme in the United Kingdom, similar to those in the United States and the Netherlands. The United Kingdom===Department of Health and Social Care has acknowledged the issue, alerting clinicians and boosting research, but campaigners argue for more comprehensive action to address this 'silent scandal' that has affected generations.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard